TABLE 1.

Neurological and psychiatric comorbidities, predisposing and precipitating factors, investigations, and treatments in patients with functional motor disorders (N = 410)

Variables	N	%
Neurological comorbidities	70	17.1
Migraine	26	6.3
Parkinsonism	13	3.2
Neuropathy	11	2.7
Hyperkinetic motor disorders	8	2.0
Seizures	8	2.0
Multiple sclerosis	5	1.2
Stroke	5	1.2
Psychiatric comorbidities	165	40.2
Anxiety disorders	110	26.8
Major depressive disorders	55	13.4
Somatoform disorder	19	4.6
Eating disorder	10	2.4
Fugue state	9	2.2
Personality disorder	8	2.0
Posttraumatic stress disorder	6	1.5
Bipolar disorder	5	1.2
Impulse control disorder/obsessive compulsive disorder	5	1.2
Sexual dysfunction	4	1.0
Schizophrenia	3	0.7
Gender dysphoria	1	0.2
Familiarity for neurological diseases	94	22.9
Childhood Predisposing factors	38	9.3
Psychological trauma	25	6.1
Physical trauma	8	2.0
Both psychological and physical trauma	5	1.2
Precipitating factors	206	50.2
Psychological trauma	114	27.8
Surgery	63	15.4
Physical trauma	50	12.2
General anesthesia	33	8.0
Infections	18	4.4
Adverse drug reactions	16	3.9
Instrumental investigations	386	94.1
Magnetic resonance imaging	357	87.1
Computerized tomography	149	36.3
Dopamine transporter single‐photon emission computed tomography	61	14.9
Electroencephalography	48	11.7
Neurophysiological tests	101	24.6
Other tests	51	12.4
Oral medications	209	50.9
Antidepressants a	135	32.9
Benzodiazepines b	111	27.1
Antiepileptics c	73	17.8
Antipsychotic drugs d	35	8.5
Other drugs	77	18.8
Other treatments	180	43.9
Physiotherapy	116	28.3
Botulinum toxin injection	52	12.7
Cognitive behavioral therapy	42	10.2
Other therapies	40	9.8

^aAmitriptyline, duloxetine, and paroxetine.

^bClonazepam.

^cPregabalin, gabapentin, and valproic acid.

^dQuetiapine and olanzapine.